| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |